HAYSTACKID Announces Deployment of New eCTD Compliance Review Module

Press Release (ePRNews.com) - Washington, DC - Nov 11, 2016 - ​​Haystack Information Discovery (“HAYSTACKID”), an international eDiscovery and digital forensics solutions provider, announced today the release of its new eCTD Compliance Review Module. Currently, this is the industry’s only available solution for handling review, analysis, and production of electronic Common Technical Document (“eCTD”) files within the Relativity environment.

With the U.S. Food and Drug Administration’s May 2017 compliance submission deadline for all New Drug Applications (NDA), Abbreviated New Drug Applications (ANDA), and Biologics Licensing Agreements (BLA) quickly approaching, the FDA has made it clear that any applications submitted after that date that do not adhere to the new eCTD standards will be automatically rejected.

“eDiscovery just was not prepared for eCTD. These files are highly complex data structures that are simply not compatible with current eDiscovery processing and review products.”

Michael Sarlo, Global Director of eDiscovery

These new regulatory requirements have caused a paradigm shift in the way Pharmaceutical Manufacturing, Drug Marketing, Biotechnology, and R&D companies now handle their application submissions, which, as a result, have also caused a ripple effect in the legal industry.

“eDiscovery just was not prepared for eCTD,” said HAYSTACKID Global Director of eDiscovery Michael Sarlo. “These files are highly complex data structures that are simply not compatible with current eDiscovery processing and review products.”

eCTD load files contain deep folder structure levels, or “modules,” correlating to specific document types and relating to various required topics when submitting an application to the FDA for review, renewal, or approval. These applications contain years of cumulative work product, all of which can be critical to any review of the contents contained within.

The complicated structure of eCTD files has spurred a greater need among attorneys, litigators, corporate counsel, patent specialists, and regulatory proceeding experts for robust access to internal metadata related to eCTD submissions.

In response to the market’s need for a solution, HAYSTACKID developed a purpose-built application that enables conversion of eCTD files with a seamless connector directly into Relativity for an optimized review experience, all within seconds.

“Structure is critical with eCTD files, and the Relativity folder tree is a perfect compendium of display,” Jefferey Stevens, HAYSTACKID Chief Technology Officer, explained. “With our new module, everything a user needs to understand about an eCTD submission is available in Relativity, where it can also be dynamically searched, culled, tagged, redacted, and acted on for production or review.”

Since adding the eCTD Compliance Review Module to its Relativity extensibility line-up, HAYSTACKID has become the premier eDiscovery provider in eCTD reviews for the top law firms, corporations, and other relevant entities around the world.

About HAYSTACKID

HAYSTACKID is an international eDiscovery and digital forensics solutions provider, with office locations throughout North America and Europe. HAYSTACKID provides corporate customers and their counsel with cost predictability options that allow accurate budgeting and forecasting of their discovery expenses without the additional cost of software, hardware or implementation fees. HAYSTACKID is headquartered in Boston with offices in New York; Washington, D.C.; Chicago; Dallas; Houston; Los Angeles; San Diego; San Francisco; Beaverton, Oregon; Paris, France; Toronto, Canada; and Frankfurt & Berlin, Germany. 

Press Contact 
media@haystackid.com 
877.9.HAYSTACK (877.942.9782)

Source : HAYSTACKID
Business Info :
HAYSTACKID

You may also like this  

DISCLAIMER : If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/services/business mentioned and hereby disclaims any content contained in this press release.

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login